Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response

Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response

US Patent 9957301 · Granted May 1, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human porphobilinogen deaminase derived proteins and polynucleotides and uses th2022
Method for preparing multiple antigen glycopeptide carbohydrate conjugates2021
Vectors for molecule delivery to CD11b expressing cells2018
Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery o2017
Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applicat2017
Recombinant adenylate cyclase toxin of bordetella induces T cell responses again2016
Recombinant protein carrying human papillomavirus epitopes inserted in an adenyl2016
Vectors for molecule delivery to CD11b expressing cells2016
Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery o2015
Agents and methods based on the use of the EDA domain of fibronectin2015
Therapy of cancer based on targeting adaptive, innate and/or regulatory componen2015
Therapy of cancer based on targeting adaptive, innate and/or regulatory componen2015